Two die from bootleg weight loss drug
Two individuals died after consuming unauthorized versions of the unapproved weight loss drug retatrutide, according to FDA adverse event reports. The deaths involve cardiac arrest cases in July and September, joining at least 14 hospitalizations linked to gray-market sales of the experimental medication.